RF
Publicaties op Oncologisch.com
Ribociclib Plus Endocrine Therapy in Hormone Receptor-Positive/ERBB2-Negative Early Breast Cancer: 4-Year Outcomes Fr...
Health-Related Quality of Life in Patients with HR+/HER2- Early Breast Cancer Treated with Ribociclib Plus a Nonstero...
Ribociclib plus endocriene therapie bij vroeg mammacarcinoom: NATALEE fase III
Neoadjuvant trastuzumab-pertuzumab-chemotherapie versus T-DM1-pertuzumab bij HER2-positief mammacarcinoom: KRISTINE